Drug class
Varicella-Zoster Immune Globulin
Varicella-zoster immune globulin is a specialized class of hyperimmune human immunoglobulin preparations containing high titers of antibodies directed against the varicella-zoster virus. Read more about Varicella-Zoster Immune Globulin
2 drugs in this class 2 manufacturers
Drugs in Varicella-Zoster Immune Globulin
VARIZIG (varicella-zoster immune globulin/maltose)
Varicella-zoster immune globulin is a specialized class of hyperimmune human immunoglobulin preparations containing high titers of antibodies directed against the varicella-zoster virus.
It functions by providing immediate, passive immunity to neutralize viral particles and prevent or attenuate disease following exposure.
The class is indicated for post-exposure prophylaxis against varicella (chickenpox) in individuals at high risk for severe disease or life-threatening complications, particularly immunocompromised children and adults, non-immune pregnant women, and certain neonates or premature infants for whom the live-attenuated varicella vaccine is contraindicated.
-
fda.gov
Varicella-zoster immune globulin is a specialized class of hyperimmune human immunoglobulin preparations containing high titers of antibodies directed against the varicella-zoster virus
-
varizig.com
Varicella-zoster immune globulin is a specialized class of hyperimmune human immunoglobulin preparations containing high titers of antibodies directed against the varicella-zoster virus
-
varizig.com
It functions by providing immediate, passive immunity to neutralize viral particles and prevent or attenuate disease following exposure The class is indicated for post-exposure prophylaxis against varicella (chickenpox) in individuals at high risk for severe disease or life-threatening complications, particularly immunocompromised children and adults, non-immune pregnant women, and certain neonates or premature infants for whom the live-attenuated varicella vaccine is contraindicated
-
mayoclinic.org
It functions by providing immediate, passive immunity to neutralize viral particles and prevent or attenuate disease following exposure
-
cdc.gov
The class is indicated for post-exposure prophylaxis against varicella (chickenpox) in individuals at high risk for severe disease or life-threatening complications, particularly immunocompromised children and adults, non-immune pregnant women, and certain neonates or premature infants for whom the live-attenuated varicella vaccine is contraindicated
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.